Results 151 to 160 of about 9,177 (206)

Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA). [PDF]

Vaccines (Basel)
Abidi S, Elhazaz Fernandez A, Seehase N, Hanisch L, Karlas A, Sandig V, Jordan I.   +6 more
europepmc   +1 more source

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

, 2006
Nilu Goonetilleke, S. S. Moore, Len Dally, Nicola Winstone, Inese Cebere, Abdul Mahmoud, Susana Pinheiro, Geraldine M. Gillespie, Denise Scott Brown, Vanessa Loach, Joanna Roberts, Ana Guimarães‐Walker, Peter Hayes, Kelley Loughran, Carole Smith, Jeroen de Bont, Carl Verlinde, Danii Vooijs, Claudia Schmidt, Mark Boaz, Jill Gilmour, Pat Fast, Lucy Dorrell, Tomáš Hanke, Andrew J. McMichael   +24 more
openalex   +1 more source

Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression [PDF]

, 2009
Michael H. Lehmann, Wolfgang Kastenmüller, Judith D. Kandemir, Florian Brandt, Yasemin Suezer, Gerd Sutter   +5 more
openalex   +1 more source

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. [PDF]

Signal Transduct Target Ther
Mayer L, Weskamm LM, Addo MM.
europepmc   +1 more source

Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored Ebola Vaccines at 1 Year

Journal of the American Medical Association (JAMA), 2017
Rebecca Winslow, I. Milligan, M. Voysey, K. Luhn, Georgi Shukarev, M. Douoguih, M. Snape   +6 more
semanticscholar   +1 more source

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

, 2006
Holger Ludwig, Yasemin Suezer, Zoe Waibler, Ulrich Kalinke, Barbara S. Schnierle, Gerd Sutter   +5 more
openalex   +1 more source

Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: Attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV [PDF]

, 2009
Koen K. A. Van Rompay, Kristina Abel, Patricia L. Earl, Pamela A. Kozlowski, Juliet Easlick, Joseph Moore, Linda Buonocore-Buzzelli, Kimberli A. Schmidt, Robert L. Wilson, Ian D. Simon, Bernard Moss, Nina F. Rose, John K. Rose, Marta L. Marthas   +13 more
openalex   +1 more source

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans. [PDF]

Vaccines (Basel)
Tscherne A, Kalodimou G, Kupke A, Rohde C, Freudenstein A, Jany S, Kumar S, Sutter G, Krähling V, Becker S, Volz A.   +10 more
europepmc   +1 more source

P19-52 LB. Assessing and restructuring foreign gene insertion sites for enhanced stability of modified Vaccinia virus ankara recombinants expressing HIV genes [PDF]

, 2009
Linda S. Wyatt, Patricia L. Earl, Bernard Moss   +2 more
openalex   +1 more source

Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice. [PDF]

J Virol
Zhu J, Wang Z, Li Y, Zhang Z, Ren S, Wang J, Xie S, Liao Z, Song B, Wu W, Yan F, Peng C.   +11 more
europepmc   +1 more source